retatrutide glp 3rt vs Semaglutide and Tirzepatide: GLP-3 Facts explained GLP-3 10mg Vial (Retatrutide) |

Jia IT et al

Checking your eligibility and resources of assistance is a good idea

Endocrinology 166:bqaf028 Kaur M, Misra S (2024) A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity

The evidence in humans is less dramatic but still positive

At the standard retatrutide dose schedule starting at 1mg weekly, a single 5mg vial covers roughly five weeks of the initial titration phase

[16] There are no specific clinical tests routinely used to measure GLP-1 levels in standard medical practice, and symptoms of potential GLP-1 dysfunction are nonspecific and overlap with many other metabolic conditions